IA
HUMA icon

IFP Advisors’s Humacyte HUMA Stock Holding History

IFP Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.65K Buy
11,080
+1,960
+21% +$1.82K ﹤0.01% 3487
2026
Q1 		$5.53K Buy
9,120
+3,106
+52% +$3.23K ﹤0.01% 3456
2025
Q4 		$5.78K Buy
6,014
+4,986
+485% +$7.06K ﹤0.01% 3344
2025
Q3 		$1.79K Sell
1,028
-33
-3% -$65 ﹤0.01% 3743
2025
Q2 		$2.22K Sell
1,061
-126
-11% -$242 ﹤0.01% 3853
2025
Q1 		$2.07K Hold
1,187
– – ﹤0.01% 3139
2024
Q4 		$6.13K Buy
1,187
+987
+494% +$4.88K ﹤0.01% 2718
2024
Q3 		$1.09K Hold
200
– – ﹤0.01% 3064
2024
Q2 		$960 Buy
+200
New +$1.04K ﹤0.01% 2996

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IFP Advisors's HUMA Position: Q2 2026 in Review

IFP Advisors increased its Humacyte (HUMA) stake by 21% in Q2 2026, buying an estimated $1.82K and bringing the position to 11,080 shares worth $8.65K. The position accounts for ﹤0.01% of the portfolio, ranked #3487.

IFP Advisors first reported a position in HUMA in Q2 2024 and has held it in 9 quarters since. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • IFP Advisors held 11,080 shares of Humacyte worth $8.65K as of Q2 2026.
  • IFP Advisors bought 1,960 Humacyte shares in Q2 2026, an estimated $1.82K.
  • Humacyte made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3487 holding.
  • IFP Advisors first reported a position in Humacyte in Q2 2024 and has held it in 9 quarters since.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.